65018v1 // 5071 // (55669,9927)

Rakovic A, Grunewald A, Kottwitz J, Bruggemann N, Pramstaller PP, Lohmann K, Klein C

Mutations in PINK1 and Parkin impair ubiquitination of Mitofusins in human fibroblasts.

PLoS One 6:e16746 (2011)
DOI:10.1371/journal.pone.0016746

Devine MJ, Plun-Favreau H, Wood NW

Parkinson's disease and cancer: two wars, one front.

Nat Rev Cancer 11:812-23 (2011)
DOI:10.1038/nrc3150

Truban D, Hou X, Caulfield TR, Fiesel FC, Springer W

PINK1, Parkin, and Mitochondrial Quality Control: What can we Learn about Parkinson's Disease Pathobiology?

J Parkinsons Dis 7:13-29 (2017)
DOI:10.3233/JPD-160989

Puschmann A, Fiesel FC, Caulfield TR, Hudec R, Ando M, Truban D, Hou X, Ogaki K, Heckman MG, James ED, Swanberg M, Jimenez-Ferrer I, Hansson O, Opala G, Siuda J, Boczarska-Jedynak M, Friedman A, Koziorowski D, Rudzinska-Bar M, Aasly JO, Lynch T, Mellick GD, Mohan M, Silburn PA, Sanotsky Y, Vilarino-Guell C, Farrer MJ, Chen L, Dawson VL, Dawson TM, Wszolek ZK, Ross OA, Springer W

Heterozygous PINK1 p.G411S increases risk of Parkinson's disease via a dominant-negative mechanism.

Brain 140:98-117 (2017)
DOI:10.1093/brain/aww261